EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Primary central nervous system extranodal NK /T‐cell lymphoma, nasal type with CD20 expression: Case report and review of the literature

Jiexia Guan, Weizhen Lin, Weimin Liu, Dayang Hui iD

Neuropathology · 2024

DOI: 10.1111/neup.12954 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Neuropathology, 2024. Verfasst von Jiexia Guan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Lymphoma, Extranodal NK-T-Cell, Antigens, CD20. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary central nervous system (PCNS) extranodal NK/T‐cell lymphoma, nasal type (ENKTCL), is an exceedingly rare tumor. To the best of our knowledge, only 27 cases and only one reported aberrant CD20 expression have been documented in the literature. Here we present a second case of PCNS ENKTCL with aberrant CD20 expression in a 43‐year‐old immunocompetent Chinese female. The patient presented with tremors, weakness in the right upper limb, and a slow reaction. Magnetic resonance imaging revealed multiple brain lesions. A histological examination revealed a diffuse distribution of intermediate‐sized pleomorphic lymphocytes with angiocentric growth. The tumor cells expressed CD2, CD3, CD56, T‐cell intracellular antigen‐1, granzyme B, and Epstein–Barr virus‐encoded RNAs (EBERs), with additional partial and weak CD20 and CD30 expression. Despite a confirmatory pathological diagnosis, the patient refused treatment and was discharged, ultimately dying from the disease. In the literature review, the clinical, immunohistochemical, EBERs, treatment, and prognostic features of PCNS ENKTCL were summarized. Although PCNS ENKTCT is extremely rare, it does occur and should always be included in differential diagnoses. CD20 expression should be evaluated routinely with relevant markers. The accumulation of cases is crucial for developing an effective treatment strategy for this rare and aggressive malignancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Extranodal NK-T-CellAntigens, CD20HumansFemaleAdultCentral Nervous System NeoplasmsBrain Neoplasms

Stichwörter der Autor:innen

CD20aberrant expressiondifferential diagnosisextranodal NK/T‐cell lymphomaprimary central nervous system

Substanzen

Antigens, CD20

Autor:innen und Institutionen

  • Department of Pathology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

ORCID-Profile: Dayang Hui

Zitieren

APA

Guan, J., Lin, W., Liu, W., & Hui, D. (2024). Primary central nervous system extranodal NK /T‐cell lymphoma, nasal type with CD20 expression: Case report and review of the literature. Neuropathology. https://doi.org/10.1111/neup.12954

Vancouver

Guan J, Lin W, Liu W, Hui D. Primary central nervous system extranodal NK /T‐cell lymphoma, nasal type with CD20 expression: Case report and review of the literature. Neuropathology. 2024. doi:10.1111/neup.12954

BibTeX
@article{Guan2024,
  author = {Guan, Jiexia and Lin, Weizhen and Liu, Weimin and Hui, Dayang},
  title = {Primary central nervous system extranodal NK /T‐cell lymphoma, nasal type with CD20 expression: Case report and review of the literature},
  journal = {Neuropathology},
  year = {2024},
  doi = {10.1111/neup.12954}
}
Kostenlos starten →